Details for New Drug Application (NDA): 007392
✉ Email this page to a colleague
NDA 007392 describes SECONAL SODIUM, which is a drug marketed by Valeant Pharms North and Lilly and is included in three NDAs. Additional details are available on the SECONAL SODIUM profile page.
The generic ingredient in SECONAL SODIUM is secobarbital sodium. There is one drug master file entry for this compound. Additional details are available on the secobarbital sodium profile page.
The generic ingredient in SECONAL SODIUM is secobarbital sodium. There is one drug master file entry for this compound. Additional details are available on the secobarbital sodium profile page.
Summary for 007392
| Tradename: | SECONAL SODIUM |
| Applicant: | Lilly |
| Ingredient: | secobarbital sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 007392
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 50MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
